Associations between untreated depression and secondary health care utilization in patients with hypertension and/or diabetes.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 18 10 2017
accepted: 06 06 2018
pubmed: 28 6 2018
medline: 15 5 2019
entrez: 28 6 2018
Statut: ppublish

Résumé

We determined the prevalence of untreated depression in patients with hypertension (HT) and/or diabetes (DM) and estimated the extra health care use and expenditures associated with this comorbidity in a rural Hungarian adult population. We also assessed the potential workload of systematic screening for depression in this patient group. General health check database from a primary care programme containing survey data of 2027 patients with HT and/or DM was linked to the outpatient secondary care use database of National Institute of Health Insurance Fund Management. Depression was ascertained by Beck Depression Inventory score and antidepressant drug use. The association between untreated depression and secondary healthcare utilization indicated by number of visits and expenses was evaluated by multiple logistic regression analysis controlled for socioeconomic/lifestyle factors and comorbidity. The age-, sex- and education-specific observations were used to estimate the screening workload for an average general medical practice. The frequency of untreated depression was 27.08%. The untreated severe depression (7.45%) was associated with increased number of visits (OR 1.60, 95% CI 1.11-2.31) and related expenses (OR 2.20, 95% CI 1.50-3.22) in a socioeconomic status-independent manner. To identify untreated depression cases among patients with HT and/or DM, an average GP has to screen 42 subjects a month. It seems to be reasonable and feasible to screen for depression in patients with HT and/or DM in the primary care, in order to detect cases without treatment (which may be associated with increase of secondary care visits and expenditures) and to initiate the adequate treatment of them.

Identifiants

pubmed: 29947863
doi: 10.1007/s00127-018-1545-7
pii: 10.1007/s00127-018-1545-7
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-276

Subventions

Organisme : Swiss Contribution Programme
ID : SH/8/1
Organisme : European Union and the European Regional Development Fund
ID : GINOP-2.3.2-15-2016-00005

Références

Clin Ther. 1999 Jun;21(6):1074-90; discussion 1073
pubmed: 10440628
Diabetes Care. 2001 Jun;24(6):1069-78
pubmed: 11375373
Pain. 2001 Aug;93(2):115-21
pubmed: 11427322
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Orv Hetil. 2003 Aug 3;144(31):1521-9
pubmed: 14502866
Prim Care Companion J Clin Psychiatry. 2001 Dec;3(6):244-254
pubmed: 15014592
Psychosom Med. 2004 Jul-Aug;66(4):466-74
pubmed: 15272090
Behav Med. 2006 Winter;31(4):133-9
pubmed: 16526347
Psychosom Med. 2006 Sep-Oct;68(5):645-50
pubmed: 17012516
Arch Gen Psychiatry. 2007 Apr;64(4):485-94
pubmed: 17404125
Am J Psychiatry. 2007 Sep;164(9):1371-8
pubmed: 17728422
Gen Hosp Psychiatry. 2007 Sep-Oct;29(5):409-16
pubmed: 17888807
Int J Clin Pract. 2008 Jan;62(1):76-87
pubmed: 17983433
Circulation. 2008 Oct 21;118(17):1768-75
pubmed: 18824640
J Am Coll Cardiol. 2009 Jan 13;53(2):176-83
pubmed: 19130986
Neuropsychopharmacol Hung. 2008 Dec;10(5):265-70
pubmed: 19419011
Psychosom Med. 2009 Jun;71(5):501-7
pubmed: 19528291
Psychiatr Serv. 2009 Sep;60(9):1190-7
pubmed: 19723733
Arch Gen Psychiatry. 2009 Sep;66(9):1022-9
pubmed: 19736359
Soc Sci Med. 2010 Jul;71(2):305-313
pubmed: 20483518
Diabetologia. 2010 Dec;53(12):2470-9
pubmed: 20700575
Int J Public Health. 2011 Oct;56(5):485-91
pubmed: 21512756
PLoS One. 2011;6(5):e19590
pubmed: 21611123
Curr Cardiol Rev. 2010 Aug;6(3):138-49
pubmed: 21804773
Oman Med J. 2011 May;26(3):155-9
pubmed: 22043406
BMC Public Health. 2012 Jan 20;12:60
pubmed: 22264383
Health Syst Transit. 2011;13(5):1-266
pubmed: 22394651
Nat Rev Cardiol. 2012 Sep;9(9):526-39
pubmed: 22733213
Cardiovasc Psychiatry Neurol. 2013;2013:695925
pubmed: 23653854
Eur J Public Health. 2013 Aug;23(4):529-30
pubmed: 23882116
Eur Heart J. 2014 Jun 1;35(21):1365-72
pubmed: 24282187
Circulation. 2014 Mar 25;129(12):1350-69
pubmed: 24566200
Endocrine. 2015 Feb;48(1):14-24
pubmed: 24927794
BMC Psychiatry. 2014 Dec 24;14:371
pubmed: 25540022
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
Am J Hypertens. 2015 Nov;28(11):1295-302
pubmed: 25911639
Psychiatr Serv. 2015 Sep;66(9):992-5
pubmed: 25930042
Biopsychosoc Med. 2015 Apr 17;9:11
pubmed: 25969694
Medicine (Baltimore). 2015 Aug;94(31):e1317
pubmed: 26252317
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Am J Med Sci. 2016 Apr;351(4):387-99
pubmed: 27079345
JAMA. 2016 May 24-31;315(20):2230-2
pubmed: 27218634
PLoS One. 2016 Jul 27;11(7):e0158163
pubmed: 27463115
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
Curr Opin Psychiatry. 2016 Nov;29(6):340-5
pubmed: 27662598
Front Public Health. 2016 Sep 13;4:200
pubmed: 27679797
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
Patient Prefer Adherence. 2017 Mar 15;11:547-559
pubmed: 28352161
J Psychosom Res. 1995 Nov;39(8):1019-29
pubmed: 8926597
J Affect Disord. 1998 Sep;50(2-3):153-62
pubmed: 9858075

Auteurs

Anita Pálinkás (A)

Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, POB. 400, 4002, Hungary.

János Sándor (J)

Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, POB. 400, 4002, Hungary. sandor.janos@sph.unideb.hu.

Magor Papp (M)

National Institute of Health Promotion, Budapest, Hungary.

László Kőrösi (L)

Department of Financing, National Institute of Health Insurance Fund Management, Budapest, Hungary.

Zsófia Falusi (Z)

Department of Financing, National Institute of Health Insurance Fund Management, Budapest, Hungary.

László Pál (L)

Department of Financing, National Institute of Health Insurance Fund Management, Budapest, Hungary.

Zsuzsanna Bélteczki (Z)

Santha Kalman Mental Health Centre and Special Hospital, Nagykallo, Hungary.

Zoltán Rihmer (Z)

Department of Psychiatry and Psychotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Laboratory for Suicide Research and Prevention, National Institute of Psychiatry and Addictions, Budapest, Hungary.

Péter Döme (P)

Department of Psychiatry and Psychotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Laboratory for Suicide Research and Prevention, National Institute of Psychiatry and Addictions, Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH